This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Illinois. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Emily Jane Geddes: Innovator in Antibiotic Development
Introduction
Emily Jane Geddes is a prominent inventor based in Urbana, IL (US). She has made significant contributions to the field of antibiotic research, particularly focusing on compounds effective against Gram-negative pathogens. With a total of two patents to her name, Geddes is recognized for her innovative approaches to combating microbial infections.
Latest Patents
Geddes' latest patents include groundbreaking work on Ribocil C antibiotics that are effective for Gram-negative pathogens. These patents disclose antibacterial compounds that accumulate in Gram-negative bacteria, along with methods for preparing and using these compounds to inhibit or kill microbes. The research emphasizes the strategic addition of amine substituents to selected compounds, enhancing their antibacterial activity against Gram-negative bacteria. This innovative approach aims to provide effective treatments for microbial infections, particularly those caused by Gram-negative bacteria.
Career Highlights
Emily Jane Geddes is affiliated with the University of Illinois, where she continues her research and development in antibiotic compounds. Her work has garnered attention for its potential impact on public health, especially in the fight against antibiotic-resistant bacteria. Geddes' dedication to her field is evident in her commitment to developing new and effective treatments.
Collaborations
Geddes collaborates with esteemed colleagues such as Paul Joseph Hergenrother and Bryon Shane Drown. These partnerships enhance her research efforts and contribute to the advancement of antibiotic development.
Conclusion
Emily Jane Geddes stands out as an influential inventor in the realm of antibiotic research. Her innovative patents and collaborative efforts reflect her commitment to addressing critical health challenges posed by Gram-negative pathogens. Her work continues to pave the way for new treatments and advancements in microbial infection management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile